BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17986217)

  • 1. Selective enhancement of the activity of C-terminally truncated, but not intact, acetylcholinesterase.
    Zimmermann M; Grösgen S; Westwell MS; Greenfield SA
    J Neurochem; 2008 Jan; 104(1):221-32. PubMed ID: 17986217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of detergents on the activity of acetylcholinesterase and on the effectiveness of its inhibitors.
    Zimmermann M; Westwell MS; Greenfield SA
    Biol Chem; 2009 Jan; 390(1):19-26. PubMed ID: 19007306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain.
    Saxena A; Hur RS; Luo C; Doctor BP
    Biochemistry; 2003 Dec; 42(51):15292-9. PubMed ID: 14690439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo.
    Perrier NA; Salani M; Falasca C; Bon S; Augusti-Tocco G; Massoulié J
    J Neurochem; 2005 Aug; 94(3):629-38. PubMed ID: 16001972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring.
    Massoulié J; Bon S; Perrier N; Falasca C
    Chem Biol Interact; 2005 Dec; 157-158():3-14. PubMed ID: 16257397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands.
    Loewenstein Y; Gnatt A; Neville LF; Soreq H
    J Mol Biol; 1993 Nov; 234(2):289-96. PubMed ID: 8230213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations into the development of catalytic activity in anti-acetylcholinesterase idiotypic and anti-idiotypic antibodies.
    Johnson G; Moore SW
    J Mol Recognit; 2009; 22(3):188-96. PubMed ID: 19051205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformers of acetylcholinesterase: a mechanism of allosteric control.
    Taylor JL; Mayer RT; Himel CM
    Mol Pharmacol; 1994 Jan; 45(1):74-83. PubMed ID: 8302283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide derived from the C-terminal region of acetylcholinesterase modulates extracellular concentrations of acetylcholinesterase in the rat substantia nigra.
    Emmett SR; Greenfield SA
    Neurosci Lett; 2004 Apr; 358(3):210-4. PubMed ID: 15039118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acetylcholinesterase from snake venoms].
    Cousin X; Bon C
    C R Seances Soc Biol Fil; 1997; 191(3):381-400. PubMed ID: 9295965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain.
    Johnson G; Swart C; Moore SW
    Biochem J; 2008 May; 411(3):507-14. PubMed ID: 18215127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a technique to identify acetylcholinesterase C-terminal peptides in human serum samples.
    Halliday AC; Kim O; Bond CE; Greenfield SA
    Chem Biol Interact; 2010 Sep; 187(1-3):110-4. PubMed ID: 20156431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
    Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
    Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The fasciculin-acetylcholinesterase interaction].
    Marchot P
    J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholinesterase from snake venom as a model for its nerve and muscle counterpart.
    Cousin X; Bon C
    J Nat Toxins; 1999 Jun; 8(2):285-94. PubMed ID: 10410339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase.
    Liang D; Blouet JP; Borrega F; Bon S; Massoulié J
    FEBS J; 2009 Jan; 276(1):94-108. PubMed ID: 19019080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A distinct family of acetylcholinesterases is secreted by Nippostrongylus brasiliensis.
    Hussein AS; Harel M; Selkirk ME
    Mol Biochem Parasitol; 2002 Aug; 123(2):125-34. PubMed ID: 12270628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique push-pull mechanism of dealkylation in soman-inhibited cholinesterases.
    Viragh C; Akhmetshin R; Kovach IM; Broomfield C
    Biochemistry; 1997 Jul; 36(27):8243-52. PubMed ID: 9204869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.